FN1 mRNA expression of fibronectin 1 and distribution of fibronectin-associated leukocytes in humans with chronic diffuse liver diseases
AbstractChronic diffuse liver diseases are characterized by continuous progression of fibrosis, ultimately leading to cirrhosis with the following loss of the normal functioning of this organ due to excessive accumulation of the components of extracellular matrix. To find new, more available diagnostic markers of detecting disorders in the liver, we used methods of antifungal cytofluorometry and quantitative real-time polymerase chain reaction. Intensity of exposure of fibronectin and plasmatic membrane of lymphocytes in the group of patients with chronic diffuse diseases compared with the control group of practically healthy donors decreased both inside and on the surface of the cells respectively by 45.3% and 16.2%. Similar tendency towards decrease was observed during the assays of the level of the exposure of fibronectin on the surface and inside the blood granulocytes: by 25.0% and 36.5%, respectively. In the blood of the patients suffering from chronic diffuse diseases, compared with the control group, there was determined reliable increase in percentage of lymphocytes and granulocytes which contain topical fibronectin, by 32.3% and 2.78 times, correspondingly. The level of monocytes (as a percentage) with cell-associated fibronectin and fibronectin localized inside, by contrast, reliably decreased in 2.07 and 4.50 times, respectively. Analysis of the expression of FN1 in lymphocytes of blood of the studied groups using quantitative real-time polymerase chain reaction revealed decrease in the level of FN1 mRNA expression by 34.0% in the group of ill patients compared with the control group. We determined excellent diagnostic informativeness of the parameters of the level of exposure of fibronectin inside and on the surface of granulocytes and prognostic accuracy of the classifier from these parameters at the level of 100% using the method of support vector machine, SVM. High levels of diagnostic informativeness were recorded for the tests of all types of analyzed leukocytes with cell-associated fibronectin, and the classifiers based on the pair combinations of the tests with cell-associated fibronectin and fibronectin localized within the cells provide high diagnostic accuracy of the prognosis. Because the mentioned indicators are highly-sensitive tests, they can be proposed for early diagnostics and evaluation of the effectiveness of the conducted therapy of chronic diffuse liver diseases, which would allow reducing the use of paracentetic trepanobiopsy, a painful and risky procedure, which still remains the main type of diagnostic.
Allan, R. E., Luis, R. P., & Juan, P. (2017). Neutrophil-lymphocyte ratio and plateletlymphocyte ratio as prognostic factors in non-metastatic breastcancer patients from a Hispanic population. Breast Disease, 37(1), 1–6.
Altrock, Е., Wuerfel, С., Vasel, М., Kawelke, N., Dooley, S., Sottile, J., & Nakchbandi, I. A. (2015). Inhibition of fibronectin deposition improves experimental liver fibrosis. Journal of Hepathology, 62(3), 625–633.
Attallah, A., Abdallah, S., Omran, M., Farid, K., Wesam, A., Nasif, W., Shiha, G., Abdel-Aziz, A-А., Rasafy, N., & Shaker, Y. (2013). Diagnostic value of fibronectin discriminant score for predicting liver fibrosis stages in chronic hepatitis C virus patients. Annals of Hepatology, 12(1), 44–53.
Birukawa, N. K., Murase, K., Sato Y., Kosaka, A., Yoneda, A., Nishita, H., Fujita, R., Nishimura, M., Ninomiya, T., Kajiwara, K., Miyazaki, M., Nakashima, Y., Ota, S., Murakami, Y., Tanaka, Y., Minomi, K., Tamura, Y., & Niitsu, Y. (2014). Activated hepatic stellate cells are dependent on self-collagen, cleaved by membrane type 1 matrix metalloproteinase for their growth. Journal of Biological Chemistry, 289(29), 20209–20221.
Chundru, S., Kalb, B., Arif-Tiwari, H., Sharma, P., Costello, J., & Martin, C. R. (2014). MRI of diffuse liver disease: Characteristics of acute and chronic diseases. Diagnostic and Interventional Radiology, 20(3), 200–208.
Dolgikh, A. V., Netronina, O. V., Maslak, A. S., & Abraimova, O. V. (2018). Henetychesky determynyrovannye osobennosty vlyianyia molekuliarnoi struktury otdelnykh izoform fybronektina na patohenychesky znachymye protsessy metabolyzma v orhanyzme [Genetically determined features of the influence of the molecular structure of individual fibronectin isoforms on pathogenically significant metabolic processes in the body]. Laboratornaya Diagnostika, 7(3), 342–359 (in Russian).
Downey, D. G., Bell, S. C., & Elborn, J. S. (2009). Neutrophils in cystic fibrosis. Thorax, 64(1), 81–88.
Duval, F., Moreno-Cuevas, J. E., González-Garza, M. T., Maldonado-Bernal, C., & Cruz-Vega, D. E. (2015). Liver fibrosis and mechanisms of the protective action of medicinal plants targeting. Inflammation and the Immune Response, 2015, 943497.
Eddy, A. А. (2014). Overview of the cellular and molecular basis of kidney fibrosis. Kidney International Supplements, 4(1), 2–8.
Forget, M. A., Malu, S., Liu, H., Toth, C., Maiti, S., Kale, C., Haymaker, C., Bernatchez, C., Huls, H., Wang, E., Marincola, F. M., Hwu, P., Cooper, L. J., & Radvanyi, L. G. (2014). Activation and propagation of tumor infiltrating lymphocytes on clinical-grade designer artificial antigen presenting cells for adoptive immunotherapy of melanoma. Journal of Immunotherapy, 37(9), 448–460.
Germani, G., Hytiroglou, P., Fotiadu, A., Burroughs, A. K., & Dhillon, A. P. (2011). Assessment of fibrosis and cirrhosis in liver biopsies: An update. Seminars in Liver Disease, 31(1), 82–90.
Hauzenberger, D., Martin, N., & Johansson, S. (1996). Characterization of lymphocyte fibronectin. Experimental Cell Research, 222(2), 312–318.
Kryczka, J., & Boncela, J. (2015). Leukocytes: The double-edged sword in fibrosis. Mediators of Inflammation, 2015(4), 1–10.
Liu, X. Y., Liu, R. X., Hou, F., Cui, L. J., Li, C. Y., Chi, C., Yi, E., Wen, Y., & Yin, C. H. (2016). Fibronectin expression is critical for liver fibrogenesis in vivo and in vitro. Molecular Medicine Reports, 14(4), 3669–3675.
Mandrekar, J. N. (2010). Simple statistical measures for diagnostic accuracy assessment. Journal of Thoracic Oncology, 5(6), 763–764.
Maslak, A. S. (2013). Stepen razvetvlennosti N-glikanov belkov plazmy u paczientov s khronicheskim limfolejkozom na raznykh stadiyakh lecheniya [Degree of branching of N-glycans of plasma proteins in patients with chronic lymphocytic leukemia at different stages of treatment]. Zhurnal Grodnenskogo Gosudarstvennogo Mediczinskogo Universiteta, 44(4), 97–101 (in Russian).
Maslak, A. S., Kostyuk, O. V., Mashejko, I. V., & Brazaluk, A. Z. (2013) Soderzhanie α-1-kislogo glikoproteina i sialovykh kislot v biologicheskikh zhidkostyakh u bolnykh s khronicheskimi mieloproliferativnymi zabolevaniyami [The content of α-1-acid glycoprotein and sialic acids in biological fluids in patients with chronic myeloproliferative disease]. Zhurnal Grodnenskogo Gosudarstvennogo Mediczinskogo Universiteta, 41(1), 39–42 (in Russian).
Milner, R., Hung, S., Erokwu, B., Dore-Duffy, P., LaManna, J. C., & del Zoppo, G. J. (2008). Increased expression of fibronectin and the alpha 5 beta 1 integrinin angiogenic cerebral blood vessels of mice subject to hypobaric hypoxia. Molecular and Cellular Neuroscience, 38(1), 43–52.
Minchenko, O. H., Luzina, O. Y., Hnatiuk, O. S., Minchenko, D. O., Garmash, I. A., & Ratushna, O. O. (2017). Expression of tumor growth related genes in IRE1 knockdown U87 glioma cells: Effect of hypoxia. Ukrainian Biochemical Journal, 89(5), 40–51.
Netronina, O. V., Maslak, A. S., & Novik, E. U. (2018). Uroven’ lektin-svyazyvayushchikh leykotsitov v krovi bol’nykh dobrokachestvennymi pervichnymi opukholyami [Level of lectin binding white blood cells in patients with benign primary tumors]. Zhurnal Grodnenskogo Gosudarstvennogo Mediczinskogo Universiteta, 45(4), 570–572 (in Russian).
Novikov, D. K., & Novikova, V. I. (1996). Otsenka immunnogo statusa [Evaluation of the immune status]. Meditsina, Moscow (in Russian).
Park, M., Kim, Y. H., Woo, S. Y., Lee, H. J., Yu, Y., Kim, H. S., Park, Y. S., Jo, I., Park, J. W., Jung, S. C., Lee, H., Jeong, B., & Ryu, K. H. (2015). Tonsil-derived mesenchymal stem cells ameliorate CCl4-induced liver fibrosis in mice via autophagy activation. Article in Scientific Reports 5, 8616.
Pellicoro, A., Ramachandran, P., Iredale, J. P., & Fallowfield, J. A. (2014). Liver fibrosis and repair: Immune regulation of wound healing in a solid organ. Nature Reviews Immunology, 14(3), 181–194.
Peng, Y., Li, Y., He, Y., Wei, Q., Xie, Q., Zhang, L., Xia, Y., Zhou, X., Zhang, L., Feng, X., Chen, K., Chen, S., Chen, W., Long, Q., & Chai, J. (2018). The role of neutrophil to lymphocyte ratio for the assessment of liver fibrosis and cirrhosis: A systematic review. Expert Review of Gastroenterology and Hepatology, 12(5), 503–513.
Radenska-Lopovok, S. G., Korzeneva, Y. G., & Alekperov, R. T. (2015). Angiogenez i yego svyaz’ s vospaleniyem i fibrozom v khode razvitiya sistemnoy sklerodermii [Angiogenesis and its connection with inflammation and fibrosis during the development of systemic scleroderma]. Arkhiv Рatologii, 2, 56–60 (in Russian).
Sandig, H., McDonald, J., Gilmour, J., Arno, M., Lee, T. H., & Cousins, D. J. (2009). Fibronectin is a TH1-specific molecule in human subjects. The Journal of Аllergy and Сlinical Immunology. 124(3), 528–535.
Schreiber, J., Schachner, M., Schumacher, U., & Lorke, D. E. (2013). Extracellular matrix alterations, accelerated leukocyte infiltration and enhanced axonal sprouting after spinal cord hemisection in tenascin-C-deficient mice. Acta Histochemica, 115(8), 865–878.
Verloh, N., Probst, U., Utpatel, K., Zeman, F., Brennfleck, F., Werner, J. M., Fellner, C., Stroszczynski, C., Evert, M., Wiggermann, P., & Haimer, M. (2019). Influence of hepatic fibrosis and inflammation: Correlation between histopathological changes and Gd-EOB-DTPA-enhanced MR imaging. PLoS One, 14(5), 0215752.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons «Attribution» 4.0 License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.